Clinical Trials Logo

Citation(s)

  •   Hartman O, Kovanen PT, Lehtonen J, Eklund KK, Sinisalo J
    Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):92-97. doi: 10.1093/ehjcvp/pvw035.

Hydroxychloroquine for the Prevention of Recurrent Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Details for clinical trial NCT02648464